KRAS and colorectal carcinoma: For this purpose, isolated DNA (400 fmol) from the wild-type KRAS cell line Caco2 and cfDNA (200 fmol) isolated from blood sample of a CRC patient with a G12D KRAS mutation were subjected to the multiplex PEXT reaction and analyzed in triplicate with the multiplex strip test.